Hematologic Cancer Area
"Our increased knowledge and advances in treatment with immunotherapy and advanced therapies have transformed the medical care of patients who suffer from haematological cancer in recent years".
DR. CARLOS GARCÍA GRANDE COORDINATOR. HEMATOLOGIC CANCER AREA
The Hematological Cancer Department of the Cancer Center Clínica Universidad de Navarra is made up of specialists of national and international prestige.
The multidisciplinary nature of the team allows the integration of classical anatomopathological, cytological and imaging diagnostic techniques with the latest generation of immunological and molecular studies, which enables a more precise and rapid diagnosis and the use of new personalized treatments for malignant diseases of the blood and lymphatic system.
The joint work of medical and research staff facilitates the development and application of new treatments and the accurate evaluation of their results.
We are experts in the development of advanced cellular therapies, including hematopoietic progenitor transplantation, adoptive cellular immunotherapies such as CAR-T cells, dendritic cell therapies, or the use of activated lymphocytes for the treatment of infections. These treatments are developed in conjunction with the Cell Therapy Area.
In the field of lymphomas, myeloid neoplasms and, especially, in myelomas and monoclonal gammopathies, we are an international reference center, with leadership in some of the clinical trials that have allowed the development of new drugs directed to specific targets, immunoconjugated antibodies, bispecific and CART therapy.
A PERSONALIZED MEDICINE
Second Opinion,
peace of mind
Request a second opinion from our professionals with great experience in the diagnosis and treatment of oncological diseases
In 3 days, without leaving home.
Comprehensive care for our patients
IN NAVARRE AND MADRID
DISEASES
-
Acute leukemias
-
Myelodysplastic syndromes
-
Chronic myeloproliferative syndromes
-
Multiple myeloma and other monoclonal gammopathies
-
Lymphoproliferative disorders
-
Indolent and aggressive B- and T-cell non-Hodgkin lymphomas
-
Hodgkin's lymphoma
-
Mycosis fungoides, Sezary syndrome and other cutaneous lymphomas
TREATMENTS
-
Monoclonal, immunocjugated and bispecific antibodies
-
Transplantation of haematopoietic progenitors
-
CART cell therapy
-
Dendritic cell therapy
-
Target-directed drugs and immunomodulators
-
New strategies and drugs under development in clinical trials
Do you need to request a consultation with one of our specialists?
Learn more about our clinical trials
New therapeutic possibilities and advances for our patients
Advanced Therapies Unit
The Advanced Therapies Unit of the Clínica Universidad de Navarra develops cell therapies against cancer and other diseases of the immune system.
It is implemented by a highly specialised multidisciplinary team of nurses, together with doctors from all the specialties involved.
PERSONALISED TREATMENT
Therapeutic advances
Our primary objective is to enable the patient who comes to our office to receive comprehensive information, based on knowledge of the natural history of the disease, an accurate immunological and molecular diagnosis, with up-to-date therapeutic guidance, including the possibility of receiving state-of-the-art treatments and promising new drugs in the context of clinical trials, and human support from our medical and nursing staff.
GMP Cell Therapy Laboratory
This laboratory produces advanced therapy medicines under good manufacturing practices and is authorised by the Spanish Agency for Medicines and Health Products.
Specialized Nursing
Its role is focused on the monitoring of the therapeutic process, the palliation of possible adverse symptoms caused by the medication and the prevention of possible complications.
Excellence in research
The Clínica Universidad de Navarra is a pioneer in the field of cancer research and the treatment of other diseases related to the immune system.
Why choose the Clinic?
- International reference multidisciplinary team.
- Highly specialised nursing team.
- First GMP Cell Therapy Laboratory accredited in a hospital within the National Health System.
Our team of professionals
CIMA UNIVERSIDAD DE NAVARRA
Research and assistance
The collaborative group of professionals from the CIMA Universidad de Navarra and Clinic aims to understand the mechanism of transformation of normal blood cells into tumour cells in order to develop more effective treatments. Investigates minimal residual disease that may persist after treatments, its implication in relapses and strategies for its eradication.
In the laboratories of the Cima, the origin of haematological diseases is studied in order to make the transition to clinical care through clinical trials and the development of new drugs.
We help our patients overcome their stories
Your testimonials encourage us to continue improving our services.
Sven
Multiple Myeloma
"The humane treatment I have received has always been outstanding.
Before the illness I lived too much in the future and less in the present, but we must change: live the present and still have many dreams to fulfill.
Olga
Myelodysplastic Syndrome
"I never had any feeling of sadness, as far as I can remember. I didn't let it make me sad.
I am by nature an optimist, learning to be patient. I don't think about the future, the best thing for anyone is to enjoy the present.
Jon
Leukemia
"The disease was very serious but it had a cure. My life changed a lot during those years.
I had a bone marrow transplant and as soon as I recovered, I started doing what I love: going to the mountains, traveling, skiing, climbing, etc.
Amelia
Multiple Myeloma
"This clinical trial is an opportunity for me to live. It is a privilege to be able to access this novel treatment for my multiple myeloma.
I am terribly excited, I have a great desire to live because I believe it will be an important advance for me.
